Metraipolis › archive › dc_73878ea9e25c

Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42601027
DOI
10.1016/j.jped.2026.101597
License (as archived)
solo-consultazione
Archived
2026-10-16T02:45:02.057Z
SHA-256 of the archived text
e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70
Stable URL of this page
https://metraipolis.com/documento/dc_73878ea9e25c

How to cite

Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027 — Europe PMC (en), https://europepmc.org/article/MED/42601027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73878ea9e25c (Metraipolis archive dc_73878ea9e25c, sha256 e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70)
BibTeX
@misc{dc73878ea9e25c,
  title = {Gene therapy benefits in a small cohort of symptomatic 5q spinal muscular atrophy patients and real world pediatric outcomes — Europe PMC PMID:42601027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42601027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73878ea9e25c; sha256 e3b0cffa80e5af23f9352a87705c60f4804a3824a6df072263a6708c312bed70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42601027. Agents can read the archived copy with the MCP tool read_document.